Brind.

Collegium Pharmaceutical (US) stock performance lagged S&P 500 composite on August 7, 2025.

3 reports, 2 independent Updated Aug 7
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
3
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Collegium Pharmaceutical (US) stock performance lagged S&P 500 composite on August 7, 2025.

Who's involved

What this event is mainly about
Collegium Pharmaceutical (United States)

How it developed

Newest first. Tap a step to see who reported it.
  1. Collegium Pharmaceutical (US) stock performance lagged S&P 500 composite on August 7, 2025.1 source
  2. Collegium stock lagged S&P 500 gain on July 28, 2025.1 source
  3. Collegium Pharmaceutical's stock lagged the market average return.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksCompared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics Collegium Pharmaceutical (COLL) reported $188 million in revenue for the quarter ended June 2025, representin
  • StockStory3 Reasons to Avoid COLL and 1 Stock to Buy Instead Since January 2025, Collegium Pharmaceutical has been in a holding pattern, posting a small loss of 3% while floating around $31.78. The stock also
  • Unknown outlet